Iris varix as a cause of late-onset inflammation after implantation of a phakic iris claw lens [Irisvarize als Ursache einer verzögerten Entzündung nach Implantation einer Iris-Clip-Linse ins phake Auge]

Détails

ID Serval
serval:BIB_97B951B6FA78
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Iris varix as a cause of late-onset inflammation after implantation of a phakic iris claw lens [Irisvarize als Ursache einer verzögerten Entzündung nach Implantation einer Iris-Clip-Linse ins phake Auge]
Périodique
Klinische Monatsblätter Für Augenheilkunde
Auteur⸱e⸱s
Tschuor P., Hafezi F., Majo F.
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
229
Numéro
4
Pages
462-463
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Résumé
Implantation of a phakic iris claw intraocular lens is a common, effective and safe procedure to correct high myopia, hyperopia and astigmatism [2]. Due to the nature of its fixation on the iris using claws, chronic irritation and inflammation have remained a major concern with the Artisan® lens since its market introduction in 1998. Following iris claw implantation, monitoring of postoperative inflammation is mandatory [4][7]. Usually, signs of inflammation can be detected in the anterior chamber during the early postoperative period. We present here the first case of late-onset inflammation after implantation of an iris claw lens triggered by an iris varix.
The iris varix is a rare benign iris vascular abnormality, with a low prevalence as a solitary primary lesion in the general population and little is known about its clinical characteristics [1][5][6]. This report shows that an iris varix could be a cause of a late onset and chronic inflammation after phakic Artisan® lens implantation.
Mots-clé
Anti-Inflammatory Agents/therapeutic use, Dexamethasone/therapeutic use, Female, Hemangioma/drug therapy, Hemangioma/etiology, Humans, Iris Neoplasms/drug therapy, Iris Neoplasms/etiology, Middle Aged, Myopia/complications, Myopia/rehabilitation, Phakic Intraocular Lenses/adverse effects, Treatment Outcome, Uveitis/drug therapy, Uveitis/etiology
Pubmed
Web of science
Création de la notice
03/05/2012 16:34
Dernière modification de la notice
20/08/2019 15:59
Données d'usage